Overexpression of mutant IDH1 in glioma cells resulted in an increase in intracellular ROS levels, showing that the mutant IDH1 affected growth inhibition by induction of cell apoptosis and inhibition of proliferation [128]. The gene discussed is IDH1; the disease is central nervous system cancer.